ClinicalTrials.govpublic full text
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
high risk hla-a2+ melanoma, metastatic disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454070
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.